Serum Concentrations of F-Isoprostanes and 4-Hydroxynonenal in Hemodialysis Patients in Relation to Inflammation and Renal Anemia
Background Patients with end-stage renal disease (ESRD) undergoing hemodialysis (HD) are apparently exposed to enhanced oxidative stress and to inflammation. It was the aim of this study to characterize the state of systemic oxidative stress of ESRD patients before and following HD using highly spec...
Main Authors: | Ingrid Wiswedel, Daniela Peter, Andreas Gardemann, Francesco Carluccio, Hannelore Hampl, Werner Siems |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2008-01-01
|
Series: | Biomarker Insights |
Online Access: | https://doi.org/10.4137/BMI.S363 |
Similar Items
-
Serum Concentrations of F2-Isoprostanes and 4-Hydroxynonenal in Hemodialysis Patients in Relation to Inflammation and Renal Anemia
by: Ingrid Wiswedel, et al.
Published: (2008-01-01) -
Formation of 4-hydroxynonenal and further aldehydic mediators of inflammation during bromotrichlorornethane treatment of rat liver cells
by: Olaf Sommerburg, et al.
Published: (1993-01-01) -
The role of prostanoids and isoprostanes in airway inflammation
by: Clarke, Deborah Lee
Published: (2003) -
Identification of metabolic pathways of the lipid peroxidation product 4-hydroxynonenal in in situ perfused rat kidney
by: T Grune, et al.
Published: (1997-08-01) -
Metabolic fate of 4-hydroxynonenal in hepatocytes: 1,4-dihydroxynonene is not the main product
by: W G Siems, et al.
Published: (1997-03-01)